EZSolution™ Batimastat | 2540

Potent, broad spectrum matrix metalloprotease (MMP) inhibitor (IC₅₀ values are 3, 4, 4, 6 and 20 nM for MMP -1, -2, -9, -7 and -3 respectively). Exhibits antiproliferative, anti-invasive and antimetastatic activity in human ovarian carcinoma xenografts in vivo.

EZSolution™ Batimastat is a A 10 mM (1 mg in 209 µl) of the MMP inhibitor Batimastat (Cat. No.1704) in anhydrous DMSO.

2540 | EZSolution™ Batimastat DataSheet

Alternate Name/Synonyms: BB94; (2R,3S)-N4-Hydroxy-N1-[(1S)-2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl]-2-(2-methylpropyl)-3-[(2-thienylthio)methyl]butanediamide

Appearance: Liquid

Formulation: A 10 mM solution in anhydrous DMSO

CAS Number: 130370-60-4

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₂₃H₃₁N₃O₄S₂

Molecular Weight: 477.64

Cell-Permeable?: Yes

Purity: ≥98% by HPLC

Solubilities: N/A

Handling: Protect from air and moisture

Country of Origin: USA

Tag Line: A broad spectrum matrix metalloprotease (MMP) inhibitor

MDL Number: MFCD00866533

PubChem CID: 5362422

SMILES: CC(C)CC(C(CSC1=CC=CS1)C(=O)NO)C(=O)NC(CC2=CC=CC=C2)C(=O)NC

InChi: InChI=1S/C23H31N3O4S2/c1-15(2)12-17(18(22(28)26-30)14-32-20-10-7-11-31-20)21(27)25-19(23(29)24-3)13-16-8-5-4-6-9-16/h4-11,15,17-19,30H,12-14H2,1-3H3,(H,24,29)(H,25,27)(H,26,28)/t17-,18+,19+/m1/s1

InChi Key: XFILPEOLDIKJHX-QYZOEREBSA-N